- 更多网络例句与凝血激酶相关的网络例句 [注：此内容来源于网络，仅供参考]
-
Intrapleural urokinase injection on TCHT was adopted in 25 cases. Clearance of blood clot and decortication of lung was adopted in 27 cases.
采用胸膜腔内注入尿激酶法治疗25例，行血凝块清除、纤维板剥脱术治疗27例。
-
Methods 26 cases with puerperium deep venous thrombosis of the lower limbs were treated with urokinase for thrombolysis.
对26例产褥期下肢深静脉血栓形成病例应用尿激酶溶栓治疗，严密检测凝血功能及时调整剂。。
-
Carboxypeptidase inhibitor from potato , a special inhibitor of TAFIa, was used to test effect of heparin and hirudin on activation of TAFI.
对尿激酶诱导的纤溶，水蛭素比肝素有更好的间接促纤溶作用，其原因主要是水蛭素能有效抑制再次血凝的发生，减少了尿激酶和纤溶酶原的短暂性耗竭。
-
Factor XI deficiency is a rare inherited coagulation disorderassociated with prolonged activated partial thromboplastin time.
XI 因子缺乏是一种与激活部分促凝血酶原激酶时间延长有关的罕见的遗产性凝血功能紊乱性疾病。
-
In our study, we also observed the different influence between TTB-USA and RFCA on blood coagulable states (by examining the change ofα-granule membrane protein、Tissue type plasminogen activatior、Plasmingen activator inhibitor-1)、 endothelium function (by examining the change of endothelin、nitric oxide) and myocardial injury (by examining the change of creatine kinase、MB isoenzy of creatine kinase and cardiac troponin T).
为观察超声消融与射频消融对血凝状态、内皮功能及心肌损伤的影响，进一步对超声消融的安全性进行评价，我们在插管前、插管后、消融后即刻、消融后30min及48小时5次抽静脉血，分别测定血小板α-颗粒糖蛋白(GMP-140)阳性表达活化血小板百分率、内皮素、一氧化氮、组织型纤溶酶原激活剂及纤溶酶原激活剂抑制物-1(PAI-1)的变化；于消融前、消融后即刻、2hr、8hr、24hr、48hr、72hr抽取静脉血，检测肌酸激酶、肌酸激酶MB同工酶及心肌肌钙蛋白T的变化。
-
Methods According to the 4×4 Latin Square design,lytic efficacy was assessed in UK dose[(10 000 U/ml,20 000 U/ml,30 000 U/ml or 40 000 U/ml)]and the timing of Uk infusion(2,4,8,16 h after blood sample taken)and UK lytic time(2,4,8,16 h after UK infusion)in vitro.15 rabbits were subjected to the intracerebral hematoma model for analysing the effect of 2 differents UK dose(10 000 U vs 30 000 U)on brain tissue around hematoma cavity.
目的 探讨尿激酶溶解血凝块的最佳用药剂量、用药时机及药物最佳作用时间，为临床一次性清除血肿提供实验依据。方法采用2个(4×4)拉丁方设计，分析UK剂量[(1万U/ml、2万U/ml、3万U/ml、4万U/ml)]、用药时机(抽血后2、4、8、16 h)和药物作用时间(加UK后2、4、8、16 h)对溶凝效果的影响。
-
Objective To explore the effect of blood coagulation mechanism on the treatment of intracranial hematoma with urokinase.
目的 探讨尿激酶冲洗治疗颅内血肿对凝血机制的影响。
-
An enzyme in human urine that catalyzes the conversion of plasminogen to plasmin and is used in medicine to dissolve blood clot s.
尿激酶人体尿液中的可促使血将酶原转代成血浆酶的酶，用于溶解血凝块的药物中
-
An enzyme in human urine that catalyzes the conversion of plasminogen to plasmin and is used in medicine to dissolve blood clots.
尿激酶人体尿液中的可促使血将酶原转代成血浆酶的酶，用于溶解血凝块的药物中
-
Collect and send for clotting studies, P.T., P.T.T., factor five, protein "C" and S.
&|抽血样送检血栓凝血素部分促凝血酶原激酶第五因子测定蛋白质&C&和&S
- 更多网络解释与凝血激酶相关的网络解释 [注：此内容来源于网络，仅供参考]
-
APSAC anisolysated plasminogen streptokinase activated complex：苯甲氧酰纤溶酶原链激酶活化复合物
aPPT actived partial thromboplastin time 激活的部分凝血活酶时... | APSAC anisolysated plasminogen streptokinase activated complex 苯甲氧酰纤溶酶原链激酶活化复合物 | AR aortic regurgitation 主动脉瓣关闭不...
-
bleeding time：出血时间
临床疗效可预测;药代动力学特性优越,给药方法简便;与血小板或PF4无相互作用,无需监测血小板计数;对一般凝血参数如出血时间(bleeding time)、活化部分凝血激酶时间(aPTT)、凝血酶原时间(PT)、国际标准化比率(INR)无显著影响;
-
thrombocyte, blood platelet：血小板
threshold potential 阈电位 | thrombocyte, blood platelet 血小板 | thromboplastin, thrombokinase 促凝血酶原激酶, 凝血激酶
-
thrombokinase：凝血致活酶
Thrombocyte 血小板 | Thrombokinase 凝血致活酶 | Thromboplastin 促凝血酶原激酶
-
thrombokinase,thromboplastin：凝血致活激酶
凝血酶原 thrombogen | 凝血致活激酶 thrombokinase; thromboplastin | 血栓静脉炎 thrombophlebitis
-
thromboplastin, thrombokinase：促凝血酶原激酶, 凝血激酶
thrombocyte, blood platelet 血小板 | thromboplastin, thrombokinase 促凝血酶原激酶, 凝血激酶 | thromboplastinogen, anti-hemophilic globulin 凝血激酶原, 抗血友病球蛋白
-
thromboplastin injection：凝血质注射液
thromboplastin generation test 凝血激酶生长试验 | thromboplastin injection 凝血质注射液 | thrombosed external hemorrhoid 血栓外痔
-
cytozyme：凝血致活酶, 凝血激酶
cytozoicus | 细胞(内)寄生(的) | cytozyme | 凝血致活酶, 凝血激酶 | czardas | 匈牙利的民间舞蹈和音乐
-
thromboplastic：促凝血的 形成血栓的
thrombophlebitisofsigmoidsinus 乙状窦血栓性静脉炎 | thromboplastic 促凝血的 形成血栓的 | thromboplastinantecedent 促凝血酶原激酶先质
-
plasma thromboplastic component, PTC：血浆凝血激酶 第三章
plasma proteins 血浆蛋白 第三章 | plasma thromboplastic component, PTC 血浆凝血激酶 第三章 | plasma thromboplastin antecedent, PTA 血浆凝血酶前质 第三章;